Ticker: OSN, Company: Ossen Innovation Co. Ltd., Type: 6-K, Date: 2016-07-08
Original SEC Filing: Click here

---

Webplus: OSN/20160708/6-K/2_EX-99.1/000.htm SEC Original: v443938_ex99-1.htm
Ossen Innovation Enters into Non-Binding Letter of Intent with America-Asia Diabetes Research Upon completion of the Acquisition, the Company would indirectly own 90.27% of San MediTech. San MediTech’s proprietary Dynamic Glucose Monitoring System (“DGMS”) provides continuous, real-time monitoring of glucose level in diabetes patients, with two patents granted in China and several patents pending both in China and the U.S.

---

---

Webplus: OSN/20160708/6-K/1/000.htm SEC Original: v443938_6k.htm
FORM 6-K OSSEN INNOVATION CO., LTD. 518 SHANGCHENG ROAD, FLOOR 17, SHANGHAI, 200120, PEOPLE’S REPUBLIC OF CHINA Form 20-F x Form 40-F ¨ Yes ¨ No x OSSEN INNOVATION CO., LTD. Number Description 99.1 Press Release, dated July 8, 2016 6-K 1 v443938_6k.htm FORM 6-K

---

Company Information:

Ticker: OSN, Company: Ossen Innovation Co. Ltd., Type: 6-K, Date: 2016-07-08CIK: 0001485538, Location: F4, SIC: 3312, SIC Desc: STEEL WORKS, BLAST FURNACES ROLLING MILLS (COKE OVENS)
Business Phone & Address:
518 SHANGCHENG ROAD, FLOOR 17
SHANGHAI 200120